As one of four sites in the NIMH Treatment Strategies in Schizophrenia Cooperative Agreement Program, the purpose of this study is to investigate the efficacy of three drug maintenance strategies and their relationship to two psychosocial management strategies in the treatment of schizophrenic patients over two years beginning just after an acute episode. The study examines the effects of three antipsychotic drug treatments: continuous low dose (20% of standard dose); discrete targeted early intervention with placebo maintenance; and continuous standard dose. Each will be studied in combination with either supportive family management consisting of one educational workshop and monthly multiple-family meetings, or applied family management which supplements the supportive program with one year of in-home psychoeducational family treatment. Subjcts will be schizophrenic outpatients either living with or in regular contact with their family of origin, although patients will be identified for study during a period of symptom exacerbation associated with a hospitalization.

Project Start
1984-09-30
Project End
1989-08-31
Budget Start
1987-09-20
Budget End
1988-08-31
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Hospitals
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Smerud, Phyllis E; Rosenfarb, Irwin S (2008) The therapeutic alliance and family psychoeducation in the treatment of schizophrenia: an exploratory prospective change process study. J Consult Clin Psychol 76:505-10
Rosenfarb, Irwin S; Bellack, Alan S; Aziz, Nahid (2006) Family interactions and the course of schizophrenia in African American and White patients. J Abnorm Psychol 115:112-20
Blanchard, Jack J; Horan, William P; Collins, Lindsay M (2005) Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia? Schizophr Res 77:151-65
Rosenfarb, Irwin S; Bellack, Alan S; Aziz, Nahid et al. (2004) Race, family interactions, and patient stabilization in schizophrenia. J Abnorm Psychol 113:109-15
Salyers, M P; Mueser, K T (2001) Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res 48:109-23
Mueser, K T; Salyers, M P; Mueser, P R (2001) A prospective analysis of work in schizophrenia. Schizophr Bull 27:281-96
Chouljian, T L; Shumway, M; Balancio, E et al. (1995) Substance use among schizophrenic outpatients: prevalence, course, and relation to functional status. Ann Clin Psychiatry 7:19-24
Shumway, M; Chouljian, T L; Hargreaves, W A (1994) Patterns of substance use in schizophrenia: a Markov modeling approach. J Psychiatr Res 28:277-87
Galin, D; Rodgers, V; Merrin, E L (1990) Story recall under monaural and binaural conditions in psychiatric patients. Biol Psychiatry 28:794-808